Morgan Stanley’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $106K | Buy |
14,304
+2,019
| +16% | +$14.9K | ﹤0.01% | 6111 |
|
2025
Q1 | $106K | Sell |
12,285
-35,849
| -74% | -$308K | ﹤0.01% | 5986 |
|
2024
Q4 | $1.72M | Sell |
48,134
-6,435
| -12% | -$230K | ﹤0.01% | 4807 |
|
2024
Q3 | $2.58M | Sell |
54,569
-36,335
| -40% | -$1.72M | ﹤0.01% | 4469 |
|
2024
Q2 | $4.57M | Sell |
90,904
-26,803
| -23% | -$1.35M | ﹤0.01% | 3956 |
|
2024
Q1 | $13.2M | Sell |
117,707
-213,057
| -64% | -$23.9M | ﹤0.01% | 3110 |
|
2023
Q4 | $19.2M | Buy |
330,764
+291,323
| +739% | +$16.9M | ﹤0.01% | 3380 |
|
2023
Q3 | $1.25M | Buy |
39,441
+8,861
| +29% | +$281K | ﹤0.01% | 4666 |
|
2023
Q2 | $2.52M | Sell |
30,580
-45,365
| -60% | -$3.73M | ﹤0.01% | 4270 |
|
2023
Q1 | $7.8M | Buy |
75,945
+5,626
| +8% | +$578K | ﹤0.01% | 3380 |
|
2022
Q4 | $10.3M | Buy |
70,319
+6,536
| +10% | +$958K | ﹤0.01% | 3055 |
|
2022
Q3 | $10.8M | Buy |
63,783
+835
| +1% | +$141K | ﹤0.01% | 2883 |
|
2022
Q2 | $7.27M | Sell |
62,948
-23,907
| -28% | -$2.76M | ﹤0.01% | 3405 |
|
2022
Q1 | $8.66M | Buy |
86,855
+37,711
| +77% | +$3.76M | ﹤0.01% | 3075 |
|
2021
Q4 | $7.64M | Buy |
49,144
+22,428
| +84% | +$3.49M | ﹤0.01% | 3247 |
|
2021
Q3 | $6.3M | Buy |
26,716
+21,669
| +429% | +$5.11M | ﹤0.01% | 3433 |
|
2021
Q2 | $1.71M | Buy |
5,047
+4,518
| +854% | +$1.53M | ﹤0.01% | 4748 |
|
2021
Q1 | $213K | Sell |
529
-1,301
| -71% | -$524K | ﹤0.01% | 5631 |
|
2020
Q4 | $1.22M | Buy |
1,830
+1,259
| +220% | +$837K | ﹤0.01% | 4546 |
|
2020
Q3 | $265K | Sell |
571
-280
| -33% | -$130K | ﹤0.01% | 4963 |
|
2020
Q2 | $498K | Buy |
851
+656
| +336% | +$384K | ﹤0.01% | 4597 |
|
2020
Q1 | $28K | Sell |
195
-2,847
| -94% | -$409K | ﹤0.01% | 5695 |
|
2019
Q4 | $436K | Buy |
3,042
+2,340
| +333% | +$335K | ﹤0.01% | 5000 |
|
2019
Q3 | $27K | Sell |
702
-5,613
| -89% | -$216K | ﹤0.01% | 5927 |
|
2019
Q2 | $639K | Buy |
6,315
+6,042
| +2,213% | +$611K | ﹤0.01% | 4474 |
|
2019
Q1 | $36K | Sell |
273
-503
| -65% | -$66.3K | ﹤0.01% | 5810 |
|
2018
Q4 | $79K | Sell |
776
-48
| -6% | -$4.89K | ﹤0.01% | 5629 |
|
2018
Q3 | $206K | Sell |
824
-243
| -23% | -$60.8K | ﹤0.01% | 5445 |
|
2018
Q2 | $476K | Buy |
1,067
+85
| +9% | +$37.9K | ﹤0.01% | 5141 |
|
2018
Q1 | $387K | Buy |
982
+405
| +70% | +$160K | ﹤0.01% | 5149 |
|
2017
Q4 | $237K | Sell |
577
-50
| -8% | -$20.5K | ﹤0.01% | 5351 |
|
2017
Q3 | $271K | Buy |
+627
| New | +$271K | ﹤0.01% | 5208 |
|